J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on November 1, 2005

Papers In Press, published online ahead of print August 16, 2005
J. Lipid Res., doi:10.1194/jlr.M500223-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M500223-JLR200v1
46/11/2405    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Descamps, O. S.
Right arrow Articles by Heller, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Descamps, O. S.
Right arrow Articles by Heller, F. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on June 3, 2005
Revised on July 28, 2005
Accepted on August 3, 2005

Lipoprotein metabolism of pregnant women is associated with both their genetic polymorphisms and those of their newborn child

Olivier S. Descamps, Monique Bruniaux, Pierre-Francois Guilmot, Rene Tonglet, and Francis R. Heller

Internal Medicine, Hopital de Jolimont, Haine Saint-Paul 7100

Corresponding Author: descaoli{at}skynet.be

It is unclear to what extent the placenta, which expresses lipoprotein lipase (LPL) and apolipoprotein E (APOE), contributes to the lipoprotein metabolism of pregnant women. To explore this question, we took advantage of the fact that placental proteins are encoded from the fetal genome and examined the associations between lipids of 525 pregnant women and the presence, in their newborns, of genetic polymorphisms of genes involved in lipoprotein metabolism. The results demonstrated that maternal lipids were associated with the polymorphisms of newborns, independently of polymorphisms carried by the mothers. After adjustment for maternal polymorphisms, newborn LPL*S447X was associated with lower triglycerides(-21+/-9mg/dl;p=0.02), lower LDL-C(-12+/-5mg/dl;p=0.02), lower apoB(-14+/-4mg/dl;p<0.001), higher HDL-C(+5+/-2mg/dl;p=0.008) and higher apoA1(+9+/-4mg/dl;p=0.02) in their mothers; newborn LPL*N291S was associated with higher maternal triglycerides(+114+/-31mg/dl;p<0.001); newborn APOE*E2 was associated with higher maternal LDL-C(+14+/-6mg/dl;p=0.02) and higher maternal apoB(+14+/-5mg/dl;p<0.001) (compared to E3E3). These associations had same amplitudes and contributions to the variances than associations between maternal polymorphisms and lipids. These associations were also independent of newborn lipid concentrations. In conclusion, these associations between maternal lipoproteins and fetal polymorphisms supports the idea of an active role of placental LPL and APOE in maternal lipoproteins metabolism. It generates new hypothesis on the contributions of fetal genes in the various risks associated with dyslipidemia during pregnancy (pre-eclampsia, pancreatitis) or in the future risk of cardiovascular disease in women.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.